Cellular immunity in schizophrenic patients before and during neuroleptic treatment

N Müller1, M Ackenheil, E Hofschuster

  • 1Department of Neurochemistry, University of Munich, Germany.

Insights

Schizophrenia patients show altered cellular immunity, with increased lymphocyte responses and changes in T-cell populations. These immunological differences persist even without neuroleptic treatment, suggesting a role in schizophrenia.

Area of Science:

  • Immunology
  • Psychiatry
  • Cellular Biology

Background:

  • The link between immune system dysfunction and schizophrenia has been long suspected.
  • Previous research suggests potential immunological alterations in schizophrenia patients.

Purpose of the Study:

  • To investigate cellular immunity parameters in acute-stage schizophrenia patients before and during neuroleptic treatment.
  • To compare immune responses in patients versus healthy controls.

Main Methods:

  • Studied 55 acute-stage schizophrenia patients and 51 healthy controls.
  • Assessed lymphocyte responses to mitogens (PWM, PHA) and antigens.
  • Quantified CD3+, CD4+, and CD8+ T-cell counts and suppressor-cell activity.

Main Results:

  • Patients exhibited increased lymphocyte responses to pokeweed mitogen (PWM) and phytohemagglutinin (PHA) both before and during neuroleptic treatment compared to controls.
  • Reduced lymphocyte responses to specific antigens were observed in patients, particularly before treatment with tuberculin and during treatment with various antigens.
  • Elevated CD3+ and CD4+ T-cell counts and reduced suppressor-cell activity were found in patients, independent of neuroleptic medication.

Conclusions:

  • Significant alterations in cellular immunity, including T-cell numbers and function, are present in schizophrenia.
  • These immune system changes are not attributable to neuroleptic treatment, indicating a potential intrinsic role in the pathophysiology of schizophrenia.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...